aortoiliac occlusive disease


Also found in: Wikipedia.

a·or·to·il·i·ac oc·clu·sive dis·ease

obstruction of the abdominal aorta and its main branches by atherosclerosis.

a·or·to·il·i·ac oc·clu·sive dis·ease

(ā-ōr'tō-il'ē-ak ŏ-klū'siv di-zēz')
Obstruction of the abdominal aorta and its main branches by atherosclerosis.
aortoiliac occlusive disease atherosclerotic obstruction of the abdominal aorta and its main branches, causing severe lower-limb ischaemia
References in periodicals archive ?
A prospective, multicenter, randomized controlled trial involving 168 iliac arteries in 125 patients with severe aortoiliac occlusive disease indicated that covered stents were significantly more likely to remain free from restenosis than those that were treated with a bare-metal stent ( P = 0.
A systematic review of endovascular treatment of extensive aortoiliac occlusive disease.
Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease.
In May 2011, a 44-year-old man presented with a 3-week history of rest pain of the left leg due to aortoiliac occlusive disease.
In a patient with aortoiliac occlusive disease the lower extremity arterial flow is dependent on these arteries and such a condition can cause lower extremity claudication [11].
Internal thoracic arteryinferior epigastric artery as a collateral pathway in aortoiliac occlusive disease.
Vascular surgeons and other medical specialists from around the world provide 302 chapters on current therapy in vascular and endovascular surgery for cerebrovascular disease, upper extremity arterial disease, aortic aneurysms, lower extremity aneurysms, aortoiliac occlusive disease, lower extremity occlusive disease, embolic diseases of the extremities, amputations, vascular trauma, mesenteric vascular disease, renovascular disease, arteriovenous fistulas and malformations, venous disease, and lymphatic disease, as well as angioaccess surgery.
Aortoiliac occlusive disease (AIOD), a disorder of the circulatory system that occurs when the iliac arteries narrow or become blocked, greatly affects a per son's quality of life.
Lantheus imaging products include the echocardiography contrast agent DEFINITY[R] Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, ABLAVAR([R]) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite([R])(Technetium Tc99m Generator), Cardiolite([R]) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).
Lantheus imaging products include the echocardiography contrast agent DEFINITY([R]) Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, ABLAVAR([R]) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite([R]) (Technetium Tc99m Generator), Cardiolite([R]) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).
Lantheus imaging products include the echocardiography contrast agent DEFINITY[R] Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, ABLAVAR[R] (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite[R] (Technetium Tc 99m Generator), Cardiolite[R] (Kit for the Preparation of Technetium Tc 99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).
Lantheus imaging products include the echocardiography contrast agent DEFINITY([R]) Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border; ABLAVAR([R]) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease; TechneLite([R]) (Technetium Tc99m Generator), Cardiolite([R]) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).